We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.92B
AUM Growth
+$461M
Cap. Flow
+$989M
Cap. Flow %
51.61%
Top 10 Hldgs %
63.63%
Holding
876
New
346
Increased
83
Reduced
114
Closed
295

Sector Composition

Rank Sector Weight
1 Healthcare 11.9%
2 Consumer Discretionary 11.6%
3 Financials 6.59%
4 Technology 3.07%
5 Industrials 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFX
751
DELISTED
Golden Falcon Acquisition Corp.
GFX
-85,956
Closed -$831K
AURCU
752
DELISTED
Aurora Acquisition Corp. Unit
AURCU
-33,700
Closed -$349K
ARBG
753
DELISTED
Aequi Acquisition Corp
ARBG
-201,538
Closed -$1.95M
ARBGU
754
DELISTED
Aequi Acquisition Corp Unit
ARBGU
-82,063
Closed -$821K
AJRD
755
CALL
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-33,200
Closed -$8K
HGEN
756
CALL
DELISTED
HUMANIGEN, INC.
HGEN
-15,200
Closed -$29K
HGEN
757
DELISTED
HUMANIGEN, INC.
HGEN
-2,097
Closed -$40K
GRNAW
758
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
-46,234
Closed -$40K
CYXT
759
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
-50,000
Closed -$497K
PNTM.U
760
DELISTED
Pontem Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
PNTM.U
-152,851
Closed -$1.51M
PNTM
761
DELISTED
Pontem Corporation
PNTM
-100,000
Closed -$968K
EUCR
762
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
-65,296
Closed -$652K
HZON
763
DELISTED
Horizon Acquisition Corporation II
HZON
-11,934
Closed -$122K
ML
764
DELISTED
MoneyLion Inc.
ML
-34,377
Closed -$10.3M
ARVL
765
DELISTED
Arrival Ordinary Shares
ARVL
-1,486
Closed -$1.19M
SIOX
766
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-22,500
Closed -$3K
SIOX
767
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-22,500
Closed -$59K
SIOX
768
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-22,500
Closed -$43K
BGSX.U
769
DELISTED
Build Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
BGSX.U
-34,702
Closed -$343K
CLAA.U
770
DELISTED
Colonnade Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
CLAA.U
-16,970
Closed -$167K
HERAU
771
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
-10,242
Closed -$102K
FPAC
772
DELISTED
Far Peak Acquisition Corporation
FPAC
-30,227
Closed -$295K
LGACU
773
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
-750,000
Closed -$7.5M
CTAQ
774
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
-38,843
Closed -$376K
VLDR
775
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
-94,200
Closed -$1.07M

Similar funds

Cowen and Company's Q2 2021 Portfolio in Review

As of Q2 2021, Cowen and Company held 876 positions worth $1.92B, up 32% from $1.45B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cowen and Company deployed $989M of net new capital in Q2 2021, opening 346 new positions and adding to 83 existing holdings. Its largest new stake was Home Depot: 320,000 shares worth $99.8M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Foresight Acquisition Corp. Units, an estimated $6.05M trimmed.

  • Cowen and Company's largest Q2 2021 buy was Home Depot: 320,000 shares worth $99.8M.
  • Cowen and Company added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $97.8M increase.
  • Cowen and Company's biggest Q2 2021 reduction was Foresight Acquisition Corp. Units, cutting an estimated $6.05M.
  • Cowen and Company fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2021, selling an estimated $107M.
  • Cowen and Company's ten largest holdings make up 64% of its $1.92B portfolio in Q2 2021.
  • Cowen and Company opened 346 new positions and closed 295 in Q2 2021.
  • Cowen and Company's portfolio value rose 32% quarter-over-quarter to $1.92B.

Based on Cowen and Company's 13F filing for Q2 2021, filed 13 Aug 2021.